Ikapharmindo Putramas Tbk. vs Phapros Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume), while Phapros Tbk. trades at Rp300 (market cap 221.76B, 7.89M 24h volume). The key difference: Ikapharmindo Putramas Tbk. is the larger of the two by market cap, and Phapros Tbk. is more actively traded (7.89M versus 215.9K). Which is the better fit depends on your goals.
| IKPM | PEHA | |
|---|---|---|
Market Cap | 330.19B | 221.76B |
Volume | 215.9K | 7.89M |
Lot | 2.16K | 78.91K |
Turnover | 42.44M | 2.48B |
Average Price | 196.56 | 314.91 |
Value | 42.44M | 2.48B |
Indicative Equilibrium Price | 199 | 300 |
Indicative Equilibrium Volume | 9 | 1.06K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →